Back to results
US 2021/0196834 A1Published application
Anti-sez6 antibody drug conjugates and methods of use
AssigneeAbbvie Stemcentrx LLC
InventorsDavid LIU, Julia GAVRILYUK, Alexander SCHAMMEL
Life of this patent
Estimating the term…
Abstract
Provided are novel anti-SEZ6 antibodies and antibody drug conjugates, and methods of using such anti-SEZ6 antibodies and antibody drug conjugates to treat cancer.
Claims2
-19. (canceled)
A calicheamicin drug linker, or a pharmaceutically acceptable salt or solvate thereof, comprising the structure:
Dependencies are inferred from the claim text.